| Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up B Eichhorst, T Robak, E Montserrat, P Ghia, CU Niemann, AP Kater, ... Annals of Oncology 32 (1), 23-33, 2021 | 937 | 2021 |
| Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up MA Dimopoulos, P Moreau, E Terpos, MV Mateos, S Zweegman, G Cook, ... Hemasphere 5 (2), e528, 2021 | 692 | 2021 |
| Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced … M Herold, A Haas, S Srock, S Neser, KH Al-Ali, A Neubauer, G Dölken, ... Journal of Clinical Oncology 25 (15), 1986-1992, 2007 | 640 | 2007 |
| Neutropenic enterocolitis in adults: systematic analysis of evidence quality M Gorschlüter, U Mey, J Strehl, C Ziske, M Schepke, IGH Schmidt‐Wolf, ... European journal of haematology 75 (1), 1-13, 2005 | 325 | 2005 |
| Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine C Ziske, C Schlie, M Gorschlüter, A Glasmacher, U Mey, J Strehl, ... British journal of cancer 89 (8), 1413-1417, 2003 | 206 | 2003 |
| Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care S Simons, S Ringsdorf, M Braun, UJ Mey, PF Schwindt, YD Ko, ... Supportive Care in Cancer 19, 1009-1018, 2011 | 195 | 2011 |
| Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma A Märten, S Renoth, T Heinicke, P Albers, A Pauli, U Mey, R Caspari, ... Human gene therapy 14 (5), 483-494, 2003 | 195 | 2003 |
| Final results of a prospective evaluation of the predictive value of interim positron emission tomography in patients with diffuse large B-cell lymphoma treated with R-CHOP-14 … C Mamot, D Klingbiel, F Hitz, C Renner, T Pabst, C Driessen, U Mey, ... Journal of clinical oncology 33 (23), 2523-2529, 2015 | 190 | 2015 |
| Evaluation of an ultrasound-guided technique for central venous access via the internal jugular vein in 493 patients U Mey, A Glasmacher, C Hahn, M Gorschlüter, C Ziske, M Mergelsberg, ... Supportive care in cancer 11, 148-155, 2003 | 160 | 2003 |
| Abdominal infections in patients with acute leukaemia: a prospective study applying ultrasonography and microbiology M Gorschlüter, G Marklein, K Höfling, R Clarenbach, S Baumgartner, ... British journal of haematology 117 (2), 351-358, 2002 | 134 | 2002 |
| Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†☆ P Fenaux, D Haase, V Santini, GF Sanz, U Platzbecker, U Mey Annals of Oncology 32 (2), 142-156, 2021 | 116 | 2021 |
| High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma: a meta-analysis J Strehl, U Mey, A Glasmacher, B Djulbegovic, C Mayr, M Gorschluter, ... Haematologica 88 (11), 1304-1315, 2003 | 113 | 2003 |
| Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab … P Borchmann, H Haverkamp, A Lohri, U Mey, S Kreissl, R Greil, ... The Lancet Oncology 18 (4), 454-463, 2017 | 93 | 2017 |
| Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients M Gorschlüter, U Mey, J Strehl, V Schmitz, C Rabe, K Pauls, C Ziske, ... BMC infectious diseases 6, 1-11, 2006 | 89 | 2006 |
| Efficacy and safety of ibrutinib combined with standard first-line treatment or as substitute for autologous stem cell transplantation in younger patients with mantle cell … M Dreyling, JK Doorduijn, E Gine, M Jerkeman, J Walewski, M Hutchings, ... Blood 140 (Supplement 1), 1-3, 2022 | 87 | 2022 |
| ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma C Buske, M Hutchings, M Ladetto, V Goede, U Mey, P Soubeyran, ... Annals of Oncology 29 (3), 544-562, 2018 | 78 | 2018 |
| Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma UJM Mey, KS Orlopp, D Flieger, JW Strehl, AD Ho, M Hensel, C Bopp, ... Cancer investigation 24 (6), 593-600, 2006 | 78 | 2006 |
| Advances in the treatment of hairy-cell leukaemia U Mey, J Strehl, M Gorschlüter, C Ziske, A Glasmacher, H Pralle, ... The Lancet Oncology 4 (2), 86-94, 2003 | 66 | 2003 |
| Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination … C Driessen, M Kraus, M Joerger, H Rosing, J Bader, F Hitz, C Berset, ... Haematologica 101 (3), 346, 2016 | 62 | 2016 |
| Acute transient encephalopathy after paclitaxel infusion: report of three cases CG Ziske, B Schöttker, M Gorschlüter, U Mey, R Kleinschmidt, U Schlegel, ... Annals of oncology 13 (4), 629-631, 2002 | 61 | 2002 |
